Clinical Trial Update: Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg) [Phase 2]

View source ↗

Summary

This Phase 2 open-label trial evaluated open-label anecortave acetate sterile suspension (15 mg) for pseudovitelliform detachment; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudovitelliform Detachment

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Pseudovitellium Detachment, Eye Diseases | Phase 2 | Status: COMPLETED